Sigma Planning »

Kalaris Therapeutics shares owned by Sigma Planning

Quarter-by-quarter ownership of Kalaris Therapeutics (KLRS) shares owned by Sigma Planning from 13F filings

Historical chart of Sigma Planning investment in Kalaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kalaris Therapeutics held by Sigma Planning consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalaris Therapeutics by Sigma Planning

Quarter filed Position value Share count Share price at filing
2026-06-30 $41k 10k 4.07

More positions owned by Sigma Planning

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
NVIDIA Corporation (NVDA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Core Div Grwth (DGRO)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Alphabet Cap Stk Cl A (GOOGL)
Micron Technology (MU)

View all positions for Sigma Planning

Top funds holding Kalaris Therapeutics

Samsara BioCapital
Rtw Investments
Alyeska Investment Group
Siren
Vanguard Capital Management
Ikarian Capital
UBS Group
Renaissance Technologies
Marshall Wace
Geode Capital Management
ADAR1 Capital Management
Woodline Partners
Whi Trust
Raymond James Financial
Citadel Advisors

View all funds holding Kalaris Therapeutics